These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9377775

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there.
    Llovet JM, Schwartz M, Fuster J, Bruix J.
    Semin Liver Dis; 2006 Aug; 26(3):248-53. PubMed ID: 16850374
    [Abstract] [Full Text] [Related]

  • 24. Liver transplantation for hepatocellular carcinoma in children.
    Sevmis S, Karakayali H, Ozçay F, Canan O, Bilezikci B, Torgay A, Haberal M.
    Pediatr Transplant; 2008 Feb; 12(1):52-6. PubMed ID: 18186889
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.
    Kulik LM, Mulcahy MF, Hunter RD, Nemcek AA, Abecassis MM, Salem R.
    Liver Transpl; 2005 Sep; 11(9):1127-31. PubMed ID: 16123954
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.
    Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Brú C, Navasa M, Ayuso MC, Solé M, Real MI, Vilana R, Rimola A, Visa J, Rodés J.
    Hepatology; 1998 Jun; 27(6):1572-7. PubMed ID: 9620329
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
    Olthoff KM, Forner A, Hübscher S, Fung J.
    Liver Transpl; 2011 Oct; 17 Suppl 2():S26-33. PubMed ID: 21656653
    [No Abstract] [Full Text] [Related]

  • 35. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].
    Fan J, Xu Y.
    Zhonghua Wai Ke Za Zhi; 2008 Nov 01; 46(21):1602-5. PubMed ID: 19094749
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Liver transplantation for hepatocellular carcinoma?
    Van Thiel DH, Colantoni A, De Maria N.
    Hepatogastroenterology; 1998 Nov 01; 45(24):1944-9. PubMed ID: 9951845
    [Abstract] [Full Text] [Related]

  • 38. Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma.
    Volk ML, Marrero JA, Lok AS, Ubel PA.
    Transplantation; 2006 Nov 15; 82(9):1136-9. PubMed ID: 17102762
    [Abstract] [Full Text] [Related]

  • 39. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
    Schwartz M, Roayaie S, Llovet J.
    J Hepatol; 2005 Oct 15; 43(4):584-9. PubMed ID: 16120468
    [No Abstract] [Full Text] [Related]

  • 40. Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation.
    Castroagudín JF, González-Quintela A, Martínez J, Tomé S, Forteza J, Varo E.
    Hepatogastroenterology; 2002 Oct 15; 49(43):249-51. PubMed ID: 11941967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.